Internal medicine journal
The most recent articles from:
Intern Med J
-
Internal medicine journal · Aug 2024
Omalizumab for management of hypersensitivity reactions to anticancer drugs.
Hypersensitivity reactions to anticancer drugs include treatment-limiting toxicity. Standard drug desensitisation offers temporary tolerance and hence requires repetition. ⋯ Seven of the eight patients in the current study successfully resumed the desired anticancer drug regimen without standard desensitisation. No safety issues from omalizumab were observed.